The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

about

ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression

P2860

Q33829405-2B6AD556-96A7-457A-AE31-880B33FD7456

P2860

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

Item

http://www.wikidata.org/entity/Q38886817

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

@en

type

Item

label

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

@en

prefLabel

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

@en

P1476

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

@en

P2093

Anne W Hamburger

http://www.w3.org/2001/XMLSchema#string

Bret A Hassel

http://www.w3.org/2001/XMLSchema#string

Heather Ezelle

http://www.w3.org/2001/XMLSchema#string

Smita Awasthi

http://www.w3.org/2001/XMLSchema#string

P2860

Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation

The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.

Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin

Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers.

Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase

Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.

P2888

s11010-015-2409-z

P304

177-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-015-2409-Z

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

405

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024908369

http://www.w3.org/2001/XMLSchema#string

P698

25876877

http://www.w3.org/2001/XMLSchema#string

P932

4449279

http://www.w3.org/2001/XMLSchema#string

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

about

P2860

P2860

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932